These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8068726)

  • 41. Translocation to rat liver mitochondria of phosphatidate phosphohydrolase.
    Freeman M; Mangiapane EH
    Biochem J; 1989 Oct; 263(2):589-95. PubMed ID: 2557000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors.
    Nakahara K; Yada T; Kuriyama M; Osame M
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1579-85. PubMed ID: 8060342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between the displacement of phosphatidate phosphohydrolase from the membrane-associated compartment by chlorpromazine and the inhibition of the synthesis of triacylglycerol and phosphatidylcholine in rat hepatocytes.
    Martin A; Hopewell R; Martín-Sanz P; Morgan JE; Brindley DN
    Biochim Biophys Acta; 1986 May; 876(3):581-91. PubMed ID: 3011104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
    Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; Vyas KP; Kari PH; MacDonald JS
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1225-35. PubMed ID: 1904494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats.
    Park EJ; Lee S; Jeong TS; Bok SH; Lee MK; Park YB; Choi MS
    J Biochem Mol Toxicol; 2004; 18(5):279-87. PubMed ID: 15549704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies.
    Khan BV; Fungwe TV; Wilcox HG; Heimberg M
    Biochim Biophys Acta; 1990 Jun; 1044(3):297-304. PubMed ID: 2364096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.
    Singer II; Scott S; Kazazis DM; Huff JW
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5264-8. PubMed ID: 3293052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
    Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of hydrazine on the phosphatidate phosphohydrolase activity in rat liver.
    Haghighi B; Honarjou S
    Biochem Pharmacol; 1987 Apr; 36(7):1163-5. PubMed ID: 3032206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet.
    Sandhya VG; Rajamohan T
    Food Chem Toxicol; 2008 Dec; 46(12):3586-92. PubMed ID: 18809454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postnatal development and sex differences in hepatic phosphatidate phosphohydrolase activity in the rat.
    Savolainen MJ; Lehtonen MA; Ruokonen A; Hassinen IE
    Metabolism; 1981 Jul; 30(7):706-11. PubMed ID: 6264270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acyl-CoA: cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in carp-liver microsomes: effect of cold acclimation on enzyme activities and on hepatic and plasma lipid composition.
    Teichert T; Wodtke E
    Biochim Biophys Acta; 1992 Dec; 1165(2):211-21. PubMed ID: 1450216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
    Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL
    Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of hepatic cholesterol biosynthesis by fatty acids. Effects of oleate on cytoplasmic acetoacetyl-CoA thiolase, acetoacetyl-CoA synthetase and hydroxymethylglutaryl-CoA synthase.
    Salam WH; Wilcox HG; Cagen LM; Heimberg M
    Biochem J; 1989 Mar; 258(2):563-8. PubMed ID: 2565110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difficulties in the assay of phosphatidate phosphohydrolase activity. Influence of ionic strength, detergent, and selection of substrate.
    Stark M; Humble E
    Lipids; 1996 Oct; 31(10):1097-102. PubMed ID: 8898310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.